Tech Company Financing Transactions

54gene Funding Round

Adjuvant Capital, Bill & Melinda Gates Foundation and Novartis Venture Fund participated in a $15 million Series A capital raise for 54gene. The round was announced on 4/16/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

17 Sybil Iroche Lekki Phase1
Lagos, 101233
Nigeria

Phone

+234 700 054 4363

Website

www.54gene.com

Email Address

[email protected]

Overview

54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Abasi Ene-Obong

        

Chief Operating Officer

Delali Attipoe

        

Vice President

Estelle Dogbo

        

Vice President

Aminu Yakubu

        

VP - Bus. Development

Jessica Rich

        

VP - Engineering

Francis Osifo

        

VP - Operations

Zara Modibbo

        

VP - Regulatory Affairs

Kemi Williams

        

Browse more venture capital transactions:

Prev: 4/16/2020: Slite venture capital transaction
Next: 4/16/2020: Coder venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary